Publications by authors named "Jay Azmi"

Claim this Profile
B
Benefit of switching to mepolizumab from omalizumab in severe eosinophilic asthma based on patient characteristics.
Mark C Liu, Bradley Chipps, Xavier Munoz, Gilles Devouassoux, Miguel Bergna, Jay Azmi

Respir Res· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety and pharmacodynamics of mepolizumab in children with severe asthma with an eosinophilic phenotype.
Atul Gupta, Masanori Ikeda, Bob Geng, Jay Azmi, Robert G Price

J Allergy Clin Immunol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical benefit of mepolizumab replacing omalizumab in uncontrolled severe eosinophilic asthma.
Kenneth R Chapman, Frank C Albers, Bradley Chipps, Xavier Muñoz, Gilles Devouassoux, Jay Azmi

Allergy· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis